|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Review |
Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 37 Convent Drive, Room 5128, Bethesda, Maryland 20892-4264, USA
(Correspondence should be addressed to S-Y Cheng; Email: chengs{at}mail.nih.gov)
Peroxisome proliferator-activated receptors (PPARs) and thyroid hormone receptors (TRs) are members of the nuclear receptor superfamily. They are ligand-dependent transcription factors that interact with their cognate hormone response elements in the promoters to regulate respective target gene expression to modulate cellular functions. While the transcription activity of each is regulated by their respective ligands, recent studies indicate that via multiple mechanisms PPARs and TRs crosstalk to affect diverse biological functions. Here, we review recent advances in the understanding of the molecular mechanisms and biological impact of crosstalk between these two important nuclear receptors, focusing on their roles in adipogenesis and carcinogenesis.
This article has been cited by other articles:
![]() |
S. Suzuki, S. Sasaki, H. Morita, Y. Oki, D. Turiya, T. Ito, H. Misawa, K. Ishizuka, and H. Nakamura The role of the amino-terminal domain in the interaction of unliganded peroxisome proliferator-activated receptor {gamma}-2 with nuclear receptor co-repressor J. Mol. Endocrinol., September 1, 2010; 45(3): 133 - 145. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |